The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 347:1615-1617 November 14, 2002 Number 20
NextNext

C-Reactive Protein — To Screen or Not to Screen?

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Ridker, P. M.
-PubMed Citation

Prediction is very difficult, especially about the future.

— Niels Bohr

More than 20 years ago, 246 risk factors for coronary heart disease (CHD) had already been identified, and the number continues to grow.1 Advances in genomics and proteomics will provide even more candidate markers to consider for routine assessment in practice. Risk stratification is important because information about the probability of a cardiovascular event in the future can help target therapy and resources to those most likely to benefit. Of the several hundred known correlates of CHD, only a handful have had the staying power to be recommended for . . . [Full Text of this Article]


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.